Accessibility Menu

Eckert & Ziegler Se(FRA) EUZ

Market Cap€830.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)+1,159%
5 Year-68%
1 Year-25%
1 Month-4%
€13.17
-0.75%
-0.10Today
Eckert & Ziegler Se last closing stock price
MetricPriceDate
Last closeEUR 13.012026-08-31
Eckert & Ziegler Se stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.29%EUR 13.182026-08-24
1 month-4.41%EUR 13.612026-07-31
3 month-15.85%EUR 15.462026-06-02
Year to date-14.74%EUR 15.262025-12-30
1 year-24.67%EUR 17.272025-08-29
3 year+19.25%EUR 10.912023-09-01
5 year-68.29%EUR 41.032021-09-01
Since inception+1,159.05%EUR 1.051999-05-25

Eckert & Ziegler Se Financials at a Glance

Market Cap

€830.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€312.50

Net Income (TTM)

€50.02

EPS (TTM)

€0.79

P/E Ratio

16.70

Dividend

€0.22

Beta (Volatility)

0.15 (Low)

Price

€13.17

Volume

0

Open

€13.17

Previous Close

€13.17

Daily Range

€13.17 - €13.17

52-Week Range

€13.16 - €18.40

Estimated Earnings Date

N/A

EUZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eckert & Ziegler Se

Eckert & Ziegler Strahlen- und Medizintechnik AG is a holding company, which engages in the provision of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Isotope Products, Medical, and Others. The Isotope Products segment manufactures radiation sources for imaging, measurement technology, quality assurance and environmental monitoring. Its product range extends from calibration sources for advanced medical imaging systems to radiation sources for materials analysis, homeland security, and radiometric level measurements. The Medical segment produces radioactive components for diagnosis and therapy of cancer. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

1,105

CEO

Harald Hasselmann, PhD

Website

www.ezag.de

EUZ Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

20.14%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

5.99%

Dividend Yield

1.66%

Payout Ratio

N/A

Stock Overview

Market Cap

€830.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

62.58M

Volume

0

Avg. Volume

272.697

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Eckert & Ziegler Se Performance Analysis

Eckert & Ziegler Se annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 222,229,00023.2%
20232023-12-31EUR 246,092,00010.7%
20242024-12-31EUR 295,850,00020.2%
20252025-12-31EUR 311,960,0005.4%
Eckert & Ziegler Se annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.47-15.3%
20232023-12-31EUR 0.42-10.4%
20242024-12-31EUR 0.5326.1%
20252025-12-31EUR 0.7846.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€76.40

+0.9%

Gross Profit

€36.72

+0.9%

Gross Margin

48.07%

+1.0%

Market Cap

€830.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.87

+0.7%

Employees

1,105

+1.0%

Net Income

€12.06

+1.0%

EBITDA

€22.12

+0.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€151.25

-6.0%

Total Debt

€41.04

+0.8%

Accounts Receivable

€62.66

+1.2%

Inventory

€48.56

+16.8%

Long Term Debt

€31.39

+0.8%

Short Term Debt

€9.65

+1.1%

Return on Assets

10.89%

+1.2%

Return on Invested Capital

14.36%

+1.1%

Free Cash Flow

€3.84

+0.4%

Operating Cash Flow

€8.08

+0.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About EUZ

What is the current price of Eckert & Ziegler Se?

Eckert & Ziegler Se is trading at €13.17 per share.

What is the 52-week range for Eckert & Ziegler Se?

Over the past 52 weeks, Eckert & Ziegler Se has traded between €13.16 and €18.40.

How much debt does Eckert & Ziegler Se have?

As of the most recent reporting period, Eckert & Ziegler Se reported total debt of €41.04M.

How much cash does Eckert & Ziegler Se have on hand?

Eckert & Ziegler Se reported €110.22M in cash and cash equivalents in its most recent financial results.

What is Eckert & Ziegler Se’s dividend yield?

Eckert & Ziegler Se currently has a dividend yield of 1.66%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services